Page 15 | Certara

On-Demand Webinar

Combining mechanistic modeling with machine learning to predict clinical scores in inflammatory bowel disease (IBD)

Learn how QSP, virtual patients, and machine learning come together to transform IBD drug development.…

CertaraApril 29, 2025

Press Release

Certara to Participate in Upcoming Investor Conferences

RADNOR, PA — April 29, 2025 -- Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraApril 29, 2025

Press Coverage

Rare disease drug development: challenges, support and hopes for the future

Explore rare disease drug development challenges, biosimulation solutions, and IRDiRC's significant role in transforming the…

CertaraApril 29, 2025

Conference

Outsourcing in Clinical Trials East Coast 2025

- - Booth

CertaraApril 28, 2025

Publication

Interactions of Therapeutic Antibodies With Presynaptically-Released Misfolded Proteins in Neurodegenerative Diseases. A Spatial Monte-Carlo Simulation Study

The spatial progression hypothesis of misfolded tau and alpha-synuclein proteins in Alzheimer's and Parkinson's Disease…

CertaraApril 28, 2025

On-Demand Webinar

RAPS Sponsored Webcast: Regulatory Writing and Operations to Accelerate Submissions

Senior Director, Regulatory Operations and Clinical Disclosure, Certara A seasoned pharmaceutical industry veteran, Evans Richardson…

CertaraApril 24, 2025

Poster

Applications of Quantitative Systems Pharmacology Modeling for Vaccine Development

Vaccines play a crucial role in preventing diseases and thereby saving countless lives. To prevent…

CertaraApril 24, 2025

Publication

IUPHAR review: Computational Psychiatry 2.0. A new tool for supporting combination therapy of psychopharmacology with neuromodulation in schizophrenia

Recent clinical trial successes in schizophrenia with non-dopaminergic agents have rejuvenated the field after a…

CertaraApril 24, 2025

On-Demand Webinar

Streamlining Population PK Modeling with Phoenix NLME & Pirana: Bridging Efficiency and Precision in Pharmacometrics [APAC Webinar]

Senior Director, Pharmacometric Software, Certara Keith has more than 20 years of global drug development…

CertaraApril 24, 2025

Blog

SEND V4.0 – What to Expect and When to Expect It

April 24, 2025 As the Standard for Exchange of Nonclinical Data (SEND) continues to evolve…

CertaraApril 24, 2025

Combining mechanistic modeling with machine learning to predict clinical scores in inflammatory bowel disease (IBD)

Certara to Participate in Upcoming Investor Conferences

Rare disease drug development: challenges, support and hopes for the future

Outsourcing in Clinical Trials East Coast 2025

Interactions of Therapeutic Antibodies With Presynaptically-Released Misfolded Proteins in Neurodegenerative Diseases. A Spatial Monte-Carlo Simulation Study

RAPS Sponsored Webcast: Regulatory Writing and Operations to Accelerate Submissions

Applications of Quantitative Systems Pharmacology Modeling for Vaccine Development

IUPHAR review: Computational Psychiatry 2.0. A new tool for supporting combination therapy of psychopharmacology with neuromodulation in schizophrenia

Streamlining Population PK Modeling with Phoenix NLME & Pirana: Bridging Efficiency and Precision in Pharmacometrics [APAC Webinar]

SEND V4.0 – What to Expect and When to Expect It

Newsletter sign up

Quick links

Solutions

Contact